tiprankstipranks
Trending News
More News >
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
US Market

BioRestorative Therapies (BRTX) Income Statement

Compare
186 Followers

BioRestorative Therapies Income Statement

Last quarter (Q3 2024), BioRestorative Therapies's total revenue was $233.60K, an increase of 660.91% from the same quarter last year. In Q3, BioRestorative Therapies's net income was $-1.09M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 401.00K$ 145.80K$ 119.80K$ 46.00K$ 77.00K
Gross Profit
$ 372.93K$ 145.80K$ -160.87K$ -159.21K$ 77.00K
Operating Expenses
$ 11.93M$ 15.37M$ 18.98M$ 26.35M$ 2.83M
Depreciation and Amortization
$ 0.00$ 165.74K$ 120.54K$ 205.21K$ 151.96K
EBITDA
$ -11.56M$ -15.06M$ -18.85M$ -26.22M$ -9.48M
Operating Income
$ -11.56M$ -15.22M$ -18.97M$ -26.31M$ -2.75M
Other Income/Expenses
$ 2.58M$ 4.80M$ 5.75M$ -18.00M$ -8.52M
Pretax Income
$ -8.98M$ -10.42M$ -18.49M$ -44.30M$ -11.27M
Net Income
$ -8.98M$ -10.42M$ -18.02M$ -29.94M$ -12.25M
Per Share Metrics
Basic EPS
$ -1.16$ -2.47$ -4.98$ -25.21$ -31.05
Diluted EPS
$ -1.16$ -2.47$ -4.98$ -25.21$ -31.05
Weighted Average Shares Outstanding
7.76M 4.22M 3.62M 1.19M 394.70K
Weighted Average Shares Outstanding (Diluted)
7.76M 4.22M 3.62M 1.19M 394.70K
Currency in USD

BioRestorative Therapies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis